Farmacity, a company owned by cabinet member Mario Quintana, could be allowed to operate in the province of Buenos Aires, pending the opinion of Interim Attorney General Eduardo Casal and further ratification by the Supreme Court, in a case that may decide which pharmacies owned by private companies could operate in the territory of Buenos Aires.
The current law in the province allows, since 1987, the opening of pharmacies owned by single proprietors, but not by corporations such as Farmacity, as pharmacies were seen not as businesses, but rather as “a public service, an extension of the health system.” Farmacity has challenged this determination, beginning in 2012, until reaching the Supreme Court.
Mario Quintana announced that he will sell his shares in Farmacity in order to “avoid an eventual conflict of interest” with the company’s possible arrival to the country’s most populous province. However, provincial deputy Lisandro Bonelli has accused the Attorney General of yielding to pressure from Quintana.
With this case, the National Commission for the Defense of Competition (CNDC) opted to reopen the file that had been frozen 5 years ago on Farmacity, considering that the evidence presented by the pharmaceutical company was sufficient. For this reason, it had decided to charge the Argentine Pharmaceutical Confederation (COFA) and the Argentine Federation Pharmacy Chambers for discriminatory behaviors denounced by Farmacity.
Full Content: La Arena
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI